Teva To Pay $54M To End FCA Suit Alleging Bribes To Doctors
Teva Pharmaceuticals has agreed to pony up $54 million to resolve a False Claims Act case accusing it of using speaker events to bribe doctors to prescribe two of its drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article